Agrow is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. Please do not redistribute without permission.

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Eden/Taminco sign evaluation agreement

The UK-based natural micro-encapsulation company, Eden Research (Witney, Oxfordshire), has signed an exclusive evaluation agreement with Belgian speciality chemicals company Taminco (Merelbeke). The deal grants Taminco the right to evaluate Eden's nematicide product for crop protection uses until December 31st 2014. In case of a successful evaluation that could lead to a profitable business, the two companies will negotiate a global licensing arrangement to allow the commercialisation of the product. "The market for nematicides is worth around $1 billion per year at grower level and, in recent years, has seen a significant number of effective products being removed from sale due to their risk profiles," says Eden managing director Clive Newitt. He believes that Taminco will be able to commercialise Eden's natural alternative to replace some of these products' uses alongside its own soil fumigant business.

Advertisement

Topics

What to read next

Advertisement
UsernamePublicRestriction

Register

AG002325

Ask The Analyst

Please fill in the form below to send over your enquiry or check the Ask The Analyst Page to find out more about the service

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel